Dick Simon

Dick Simon is a seasoned entrepreneur and leader with extensive experience in the fields of psychedelics and community engagement. As Co-Founder and CEO of Sensorium Therapeutics since June 2021, Simon has played a pivotal role in advancing therapeutic applications of psychedelics. Dick also serves on the Steering Committee for the Psychedelic Science Funders Collaborative and holds the position of Chairman of the Advisory Council at Massachusetts General Hospital's Center for the Neuroscience of Psychedelics. Additionally, Simon is a founding member and Chair of the YPO Psychedelic Medicines for Mental Health Group and the kNOwTHEM Initiative, which focuses on raising awareness regarding societal issues. With a strong commitment to leadership and social impact, Simon co-founded the YPO Peace Action Network and has been an influential figure at RSI and The International Institute for Sustained Dialogue. Educational credentials include an MBA from Harvard Business School and a BA in History from Cornell University.